The use and reporting of patient-reported outcomes in phase III breast cancer trials

Characteristics of Clinical Trials Registered in ClinicalTrials.gov, 2007-2010

(2012) Robert M. Califf   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Assessment of quality of life in advanced breast cancer. An overview of randomized phase III trials

(2011) Krzysztof Adamowicz et al.   CANCER TREATMENT REVIEWS

Despite Law, Fewer Than One In Eight Completed Studies Of Drugs And Biologics Are Reported On Time On ClinicalTrials.gov

(2011) Michael R. Law et al.   HEALTH AFFAIRS

Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer: An Updated Systematic Review (2001–2009)

(2011) Julie Lemieux et al.   JNCI-Journal of the National Cancer Institute

Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer

(2011) Carol M. Moinpour et al.   QUALITY OF LIFE RESEARCH

The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008

(2010) David Cella et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

The Missing Voice of Patients in Drug-Safety Reporting

(2010) Ethan Basch   NEW ENGLAND JOURNAL OF MEDICINE

Health Related Quality of Life in NCI-Sponsored Cancer Treatment Trials

(2010) Ann M. O'Mara et al.   Seminars in Oncology Nursing

Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007

(2008) Ali Montazeri   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes

(2007) Dennis Revicki et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY